Zhejiang Strong Pharmaceutical Co., Ltd. – Trademark Portfolio

Entity Type: 99

Zhejiang Strong Pharmaceutical Co., Ltd. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. Currently, 1 trademark is registered. Notable registered marks include ZILEC. The owner is based in Hangzhou,Zhejiang.

No.88,Xingning West Road,Tonglu Economic

Development Zone,Tonglu

Hangzhou,Zhejiang 311508 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Zhejiang Strong Pharmaceutical Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Zhejiang Strong Pharmaceutical Co., Ltd. have?

Zhejiang Strong Pharmaceutical Co., Ltd. has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 1 cancelled.

What trademark classes does Zhejiang Strong Pharmaceutical Co., Ltd. file in?

Zhejiang Strong Pharmaceutical Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Zhejiang Strong Pharmaceutical Co., Ltd.'s most well-known trademarks?

Zhejiang Strong Pharmaceutical Co., Ltd.'s registered trademark portfolio includes well-known marks such as ZILEC. These are among 1 currently registered trademark in the portfolio.

What is Zhejiang Strong Pharmaceutical Co., Ltd.'s trademark registration success rate?

Zhejiang Strong Pharmaceutical Co., Ltd. has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.